Sarge, instead of you focusing on what they didn't do, take a...

First 42 Last

Share
Profile

Follow
peony-rose

2,843 Posts.

139

08/04/24

15:22

Post #: 73241923
Share

Originally posted by sarge17: ↑

My more considered take below, and all IMHO.

I can’t help but think Starpharma are getting owned and outmanoeuvred here. But beggars can’t be choosers.

Medixci could have invested directly in Starpharma via equity placement if they liked the tech and company so much. But they didn’t.

Medicxi could have given Starpharma non-dilutive funding in exchange for a future revenue stream from current and future commercialised products if they believed in Starpharma’s potential. But they didn’t.

Medicxi via this startup company start-up company Petalion Therapeutics could have licenced one of Starpharma’s existing pre-clinical drug candidates to develop further which would have expedited getting a drug to market. But they didn’t.

Medicxi via this start-up company could have licenced DEP-Irinotecan, DEP-Cabazitaxel or DEP-Docetaxel to take into Phase 3 trials. But they didn’t.

Instead of cash going into the bank account through a licence fee, Starpharma are instead giving away their valuable IP for equity in a start-up company that they will have a minority share in, with no control, with the real potential to get diluted down the track through circumstances, developments and decisions outside of Starpharma’s control.

IMO this research agreement and collaboration is weak and not in Starpharma’s interests. It smells. It may also be an insight into the weakness of Starpharma’s prospects going forward.

Expand

Sarge, instead of you focusing on what they didn't do, take a step back and think about what they DID DO!

Medixci see potential in what SPL have and have gained access to the technology for other cancer therapies. They have other products in mind to develop and want what SPL have got. That is what they did do.

Obviously the belief in the DEP technology and commercialisation into products is still out there. It has been shown with this announcement with Medixci. That is what they did do.

SPL Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

TLG

Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year

EMR

Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau

EBR

EBR reaches review milestone for wireless cardiac pacing device

HYT

Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep

I88

Infini rolls on with soil sampling at Portland Creek not long after making possible 'uranium history'

There are more pages in this discussion • 120 more messages in this thread...

First 42 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.6¢		Change 0.000(0.00%)		Mkt cap ! $39.58M

Open	High	Low	Value	Volume
9.7¢	9.8¢	9.4¢	$31.6K	324.0K

Buyers (Bids)

No.	Vol.	Price($)
1	97704	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
9.7¢	75000	1

View Market Depth

No.	Vol.	Price($)
1	97704	0.096
1	59000	0.095
1	11059	0.094
1	100000	0.093
1	49413	0.091

Price($)	Vol.	No.
0.097	75000	1
0.098	136	1
0.099	94163	2
0.100	162106	5
0.105	116531	4

Last trade - 16.10pm 29/08/2024 (20 minute delay)

SPL (ASX) Chart

Sarge, instead of you focusing on what they didn't do, take a...

Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year

Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau

EBR reaches review milestone for wireless cardiac pacing device

Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep

Infini rolls on with soil sampling at Portland Creek not long after making possible 'uranium history'

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sarge, instead of you focusing on what they didn't do, take a...

Top Stories

Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year

Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau

EBR reaches review milestone for wireless cardiac pacing device

Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep

Infini rolls on with soil sampling at Portland Creek not long after making possible 'uranium history'

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News